These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 8387835)
1. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type. Tao Q; Ho FC; Loke SL; Srivastava G Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236 [TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. van Gorp J; Weiping L; Jacobse K; Liu YH; Li FY; De Weger RA; Li G J Pathol; 1994 Jun; 173(2):81-7. PubMed ID: 7522272 [TBL] [Abstract][Full Text] [Related]
4. In situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas. Tsang WY; Chan JK; Yip TT; Ng CS; Wong KF; Poon YF; Ma VW Hum Pathol; 1994 Aug; 25(8):758-65. PubMed ID: 7520016 [TBL] [Abstract][Full Text] [Related]
5. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Harabuchi Y; Imai S; Wakashima J; Hirao M; Kataura A; Osato T; Kon S Cancer; 1996 May; 77(10):2137-49. PubMed ID: 8640683 [TBL] [Abstract][Full Text] [Related]
6. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Chiang AK; Chan AC; Srivastava G; Ho FC Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of Epstein-Barr virus-associated nasal T/NK cell lymphomas in southern Japan. Seki D; Ueno K; Kurono Y; Eizuru Y Auris Nasus Larynx; 2001 Jan; 28(1):61-70. PubMed ID: 11137365 [TBL] [Abstract][Full Text] [Related]
9. Frequent expression of CD3 epsilon in CD3 (Leu 4)-negative nasal T-cell lymphomas. Ohno T; Yamaguchi M; Oka K; Miwa H; Kita K; Shirakawa S Leukemia; 1995 Jan; 9(1):44-52. PubMed ID: 7845028 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726 [TBL] [Abstract][Full Text] [Related]
11. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. Kato N; Yasukawa K; Onozuka T; Kikuta H J Am Acad Dermatol; 1999 May; 40(5 Pt 2):850-6. PubMed ID: 10321634 [TBL] [Abstract][Full Text] [Related]
12. [Two cases of lethal midline granuloma thought to be of natural killer cell origin]. Tamura S; Yamanaka N; Saito T; Takano I; Hotomi M; Yokoyama M Nihon Jibiinkoka Gakkai Kaiho; 1996 Jan; 99(1):46-53. PubMed ID: 8822254 [TBL] [Abstract][Full Text] [Related]
13. Histological and immunophenotypic profile of nasal NK/T cell lymphomas from Peru: high prevalence of p53 overexpression. Quintanilla-Martinez L; Franklin JL; Guerrero I; Krenacs L; Naresh KN; Rama-Rao C; Bhatia K; Raffeld M; Magrath IT Hum Pathol; 1999 Jul; 30(7):849-55. PubMed ID: 10414505 [TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic and genotypic characterization of nasal lymphoma with polymorphic reticulosis morphology. Ohsawa M; Nakatsuka S; Kanno H; Miwa H; Kojya S; Harabuchi Y; Yang WI; Aozasa K Int J Cancer; 1999 Jun; 81(6):865-70. PubMed ID: 10362131 [TBL] [Abstract][Full Text] [Related]
15. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346 [TBL] [Abstract][Full Text] [Related]
16. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile. Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124 [TBL] [Abstract][Full Text] [Related]
17. Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Kuo TT; Shih LY; Tsang NM Int J Surg Pathol; 2004 Oct; 12(4):375-87. PubMed ID: 15494863 [TBL] [Abstract][Full Text] [Related]
18. Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: implications on cellular origin. Chiang AK; Srivastava G; Lau PW; Ho FC Hum Pathol; 1996 Jul; 27(7):701-7. PubMed ID: 8698315 [TBL] [Abstract][Full Text] [Related]
19. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types. Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306 [TBL] [Abstract][Full Text] [Related]
20. Detection of epstein-barr virus in nasal T-cell lymphoma. Makoshi T; Takahashi H; Kameya T; Yao K; Sato Y; Nakayama M; Tsuchiya B; Okamoto M Acta Otolaryngol Suppl; 2002; (547):46-9. PubMed ID: 12212593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]